General Information of Target

Target ID LDTP11849
Target Name Homeodomain-interacting protein kinase 2 (HIPK2)
Gene Name HIPK2
Gene ID 28996
Synonyms
Homeodomain-interacting protein kinase 2; hHIPk2; EC 2.7.11.1
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MSDSKEPRVQQLGLLEEDPTTSGIRLFPRDFQFQQIHGHKSSTGCLGHGALVLQLLSFML
LAGVLVAILVQVSKVPSSLSQEQSEQDAIYQNLTQLKAAVGELSEKSKLQEIYQELTQLK
AAVGELPEKSKLQEIYQELTRLKAAVGELPEKSKLQEIYQELTRLKAAVGELPEKSKLQE
IYQELTRLKAAVGELPEKSKLQEIYQELTELKAAVGELPEKSKLQEIYQELTQLKAAVGE
LPDQSKQQQIYQELTDLKTAFERLCRHCPKDWTFFQGNCYFMSNSQRNWHDSVTACQEVR
AQLVVIKTAEEQNFLQLQTSRSNRFSWMGLSDLNQEGTWQWVDGSPLSPSFQRYWNSGEP
NNSGNEDCAEFSGSGWNDNRCDVDNYWICKKPAACFRDE
Target Type
Literature-reported
Target Bioclass
Enzyme
Family
Protein kinase superfamily, CMGC Ser/Thr protein kinase family, HIPK subfamily
Subcellular location
Nucleus, PML body
Function
Serine/threonine-protein kinase involved in transcription regulation, p53/TP53-mediated cellular apoptosis and regulation of the cell cycle. Acts as a corepressor of several transcription factors, including SMAD1 and POU4F1/Brn3a and probably NK homeodomain transcription factors. Phosphorylates PDX1, ATF1, PML, p53/TP53, CREB1, CTBP1, CBX4, RUNX1, EP300, CTNNB1, HMGA1, ZBTB4 and DAZAP2. Inhibits cell growth and promotes apoptosis through the activation of p53/TP53 both at the transcription level and at the protein level (by phosphorylation and indirect acetylation). The phosphorylation of p53/TP53 may be mediated by a p53/TP53-HIPK2-AXIN1 complex. Involved in the response to hypoxia by acting as a transcriptional co-suppressor of HIF1A. Mediates transcriptional activation of TP73. In response to TGFB, cooperates with DAXX to activate JNK. Negative regulator through phosphorylation and subsequent proteasomal degradation of CTNNB1 and the antiapoptotic factor CTBP1. In the Wnt/beta-catenin signaling pathway acts as an intermediate kinase between MAP3K7/TAK1 and NLK to promote the proteasomal degradation of MYB. Phosphorylates CBX4 upon DNA damage and promotes its E3 SUMO-protein ligase activity. Activates CREB1 and ATF1 transcription factors by phosphorylation in response to genotoxic stress. In response to DNA damage, stabilizes PML by phosphorylation. PML, HIPK2 and FBXO3 may act synergically to activate p53/TP53-dependent transactivation. Promotes angiogenesis, and is involved in erythroid differentiation, especially during fetal liver erythropoiesis. Phosphorylation of RUNX1 and EP300 stimulates EP300 transcription regulation activity. Triggers ZBTB4 protein degradation in response to DNA damage. In response to DNA damage, phosphorylates DAZAP2 which localizes DAZAP2 to the nucleus, reduces interaction of DAZAP2 with HIPK2 and prevents DAZAP2-dependent ubiquitination of HIPK2 by E3 ubiquitin-protein ligase SIAH1 and subsequent proteasomal degradation. Modulates HMGA1 DNA-binding affinity. In response to high glucose, triggers phosphorylation-mediated subnuclear localization shifting of PDX1. Involved in the regulation of eye size, lens formation and retinal lamination during late embryogenesis.
TTD ID
T53952
Uniprot ID
Q9H2X6
DrugMap ID
TTOB49C
Ensemble ID
ENST00000406875.8
HGNC ID
HGNC:14402
ChEMBL ID
CHEMBL4576

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
22RV1 SNV: p.G45D .
A172 SNV: p.S1002Y .
DOTC24510 SNV: p.I875V .
HCT116 SNV: p.R792W .
HCT15 Deletion: p.G661AfsTer63 .
HEC1 SNV: p.R498Q .
HT115 SNV: p.V1121A .
LOXIMVI SNV: p.M635I .
LS123 SNV: p.L1096P .
MEWO SNV: p.H524Y; p.R1056Q .
MOLT4 SNV: p.N914K .
NCIH1048 Deletion: p.F435SfsTer14 .
NCIH2172 SNV: p.E136D .
SKN SNV: p.H540R .
SUPT1 SNV: p.R133H .
UACC257 SNV: p.H322Q .
WM1552C SNV: p.G348R .

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 1 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C960(2.84)  LDD3373  [1]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0214  AC1 HEK-293T C266(0.96)  LDD1507  [2]
 LDCM0215  AC10 HEK-293T C266(1.26)  LDD1508  [2]
 LDCM0276  AC17 HEK-293T C266(1.09)  LDD1515  [2]
 LDCM0277  AC18 HEK-293T C266(1.01)  LDD1516  [2]
 LDCM0279  AC2 HEK-293T C266(1.22)  LDD1518  [2]
 LDCM0285  AC25 HEK-293T C266(1.03)  LDD1524  [2]
 LDCM0286  AC26 HEK-293T C266(0.96)  LDD1525  [2]
 LDCM0294  AC33 HEK-293T C266(1.03)  LDD1533  [2]
 LDCM0295  AC34 HEK-293T C266(1.00)  LDD1534  [2]
 LDCM0303  AC41 HEK-293T C266(1.03)  LDD1542  [2]
 LDCM0304  AC42 HEK-293T C266(0.92)  LDD1543  [2]
 LDCM0311  AC49 HEK-293T C266(1.05)  LDD1550  [2]
 LDCM0313  AC50 HEK-293T C266(1.11)  LDD1552  [2]
 LDCM0320  AC57 HEK-293T C266(0.97)  LDD1559  [2]
 LDCM0321  AC58 HEK-293T C266(1.01)  LDD1560  [2]
 LDCM0356  AKOS034007680 HEK-293T C266(1.01)  LDD1570  [2]
 LDCM0404  CL17 HEK-293T C266(1.13)  LDD1608  [2]
 LDCM0405  CL18 HEK-293T C266(1.04)  LDD1609  [2]
 LDCM0417  CL29 HEK-293T C266(1.05)  LDD1621  [2]
 LDCM0419  CL30 HEK-293T C266(1.09)  LDD1623  [2]
 LDCM0431  CL41 HEK-293T C266(0.96)  LDD1635  [2]
 LDCM0432  CL42 HEK-293T C266(1.29)  LDD1636  [2]
 LDCM0440  CL5 HEK-293T C266(1.10)  LDD1644  [2]
 LDCM0444  CL53 HEK-293T C266(1.07)  LDD1647  [2]
 LDCM0445  CL54 HEK-293T C266(1.16)  LDD1648  [2]
 LDCM0451  CL6 HEK-293T C266(1.85)  LDD1654  [2]
 LDCM0457  CL65 HEK-293T C266(1.03)  LDD1660  [2]
 LDCM0458  CL66 HEK-293T C266(1.47)  LDD1661  [2]
 LDCM0470  CL77 HEK-293T C266(1.13)  LDD1673  [2]
 LDCM0471  CL78 HEK-293T C266(1.11)  LDD1674  [2]
 LDCM0483  CL89 HEK-293T C266(1.01)  LDD1686  [2]
 LDCM0485  CL90 HEK-293T C266(1.44)  LDD1688  [2]
 LDCM0022  KB02 G-415 C960(1.09)  LDD2332  [1]
 LDCM0023  KB03 OCUG-1 C960(2.32)  LDD2956  [1]
 LDCM0024  KB05 OCUG-1 C960(2.84)  LDD3373  [1]

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
2 Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input. Cell Chem Biol. 2024 Mar 21;31(3):565-576.e4. doi: 10.1016/j.chembiol.2023.11.015. Epub 2023 Dec 19.
Mass spectrometry data entry: PXD044402